Morgan Stanley analyst Michael Cyprys maintains $CME Group (CME.US)$ with a hold rating, and maintains the target price at $236.
According to TipRanks data, the analyst has a success rate of 57.3% and a total average return of 5.8% over the past year.
Furthermore, according to the comprehensive report, the opinions of $CME Group (CME.US)$'s main analysts recently are as follows:
The company delivered an 'exceptional quarter,' as noted by an analyst. Despite a subdued stock reaction due to elevated expectations and lack of an update on the capital return strategy, additional details from the earnings call were regarded as clear positives. The risk/reward profile for the company remains favorable in the analyst's view.
Following the Q3 report, there was a positive perspective regarding CME Group's expanding opportunities in the retail sector, along with a notable focus on significant growth from international markets.
CME Group's latest quarter set a new record, surpassing expectations with an adjusted EPS of $2.68 compared to the anticipated $2.61 and the consensus of $2.65. The company is benefiting from a heightened demand for risk management amid the uncertainties surrounding the U.S. election and the geopolitical climate.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
摩根士丹利分析師Michael Cyprys維持$芝加哥商品交易所 (CME.US)$持有評級，維持目標價236美元。
根據TipRanks數據顯示，該分析師近一年總勝率為57.3%，總平均回報率為5.8%。
此外，綜合報道，$芝加哥商品交易所 (CME.US)$近期主要分析師觀點如下：
該公司交付了一季度'異常優異'，正如一位分析師所指出的。儘管由於市場對預期高企和資本回報策略更新缺失導致股價反應溫和，但來自業績會的額外細節被認爲是明確的積極因素。在分析師看來，該公司的風險/回報配置仍然有利。
在第三季度報告後，針對芝加哥商品交易所在零售板塊不斷擴大的機遇，以及對國際市場巨大增長的關注，產生了積極的觀點。
芝加哥商品交易所最新一個季度創下了新紀錄，調整後的每股收益爲2.68美元，超過預期的2.61美元和共識預期的2.65美元。在美國大選以及地緣政治氛圍不確定性加劇的背景下，該公司正受益於對風險管理需求的增加。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
